Is the hypoxia-inducible factor pathway important in gastric cancer?

2.50
Hdl Handle:
http://hdl.handle.net/10541/76494
Title:
Is the hypoxia-inducible factor pathway important in gastric cancer?
Authors:
Griffiths, Ewen A; Pritchard, S A; Welch, I M; Price, Patricia M; West, Catharine M L
Abstract:
Tumour hypoxia is well recognised in oncology to be a key factor resulting in treatment resistance and poor prognosis. Hypoxia leads to the expression of a number of gene products that are involved in tumour progression, invasion and metastasis formation. The most important of these proteins is thought to be hypoxia-inducible factor-1alpha (HIF-1alpha), which appears to be a master regulator of the cellular response to hypoxia. HIF-1alpha expression is associated with a poor prognosis and treatment response in a number of tumour sites. There is some evidence that the HIF-1alpha pathway might be involved in gastric carcinogenesis. Studies have shown reactive oxygen species from Helicobacter pylori, associated with the development of gastric cancer, stabilise HIF-1alpha. Non-steroidal anti-inflammatory drugs, shown to reduce the risk of gastric cancer, can decrease HIF-1alpha expression. Although a large study correlating HIF-1alpha expression with prognosis is lacking in gastric cancer, the immunohistochemical expression of HIF-1alpha target genes (Glut-1, VEGF, CA9, iNOS) is associated with a poor prognosis. In addition, the targeted inhibition of HIF-1alpha has been shown to inhibit the growth of gastric tumours in animals. Increased understanding of the importance of hypoxia and the HIF-1alpha pathways may therefore hold the key to prevention strategies, improved selection of patients for adjuvant therapy and new treatments for the disease.
Affiliation:
Department of Gastrointestinal Surgery, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, South Moor Road, Wythenshawe, M23 9LT, UK.
Citation:
Is the hypoxia-inducible factor pathway important in gastric cancer? 2005, 41 (18):2792-805 Eur. J. Cancer
Journal:
European Journal of Cancer
Issue Date:
Dec-2005
URI:
http://hdl.handle.net/10541/76494
DOI:
10.1016/j.ejca.2005.09.008
PubMed ID:
16290133
Type:
Article
Language:
en
ISSN:
0959-8049
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorGriffiths, Ewen A-
dc.contributor.authorPritchard, S A-
dc.contributor.authorWelch, I M-
dc.contributor.authorPrice, Patricia M-
dc.contributor.authorWest, Catharine M L-
dc.date.accessioned2009-08-06T11:54:47Z-
dc.date.available2009-08-06T11:54:47Z-
dc.date.issued2005-12-
dc.identifier.citationIs the hypoxia-inducible factor pathway important in gastric cancer? 2005, 41 (18):2792-805 Eur. J. Canceren
dc.identifier.issn0959-8049-
dc.identifier.pmid16290133-
dc.identifier.doi10.1016/j.ejca.2005.09.008-
dc.identifier.urihttp://hdl.handle.net/10541/76494-
dc.description.abstractTumour hypoxia is well recognised in oncology to be a key factor resulting in treatment resistance and poor prognosis. Hypoxia leads to the expression of a number of gene products that are involved in tumour progression, invasion and metastasis formation. The most important of these proteins is thought to be hypoxia-inducible factor-1alpha (HIF-1alpha), which appears to be a master regulator of the cellular response to hypoxia. HIF-1alpha expression is associated with a poor prognosis and treatment response in a number of tumour sites. There is some evidence that the HIF-1alpha pathway might be involved in gastric carcinogenesis. Studies have shown reactive oxygen species from Helicobacter pylori, associated with the development of gastric cancer, stabilise HIF-1alpha. Non-steroidal anti-inflammatory drugs, shown to reduce the risk of gastric cancer, can decrease HIF-1alpha expression. Although a large study correlating HIF-1alpha expression with prognosis is lacking in gastric cancer, the immunohistochemical expression of HIF-1alpha target genes (Glut-1, VEGF, CA9, iNOS) is associated with a poor prognosis. In addition, the targeted inhibition of HIF-1alpha has been shown to inhibit the growth of gastric tumours in animals. Increased understanding of the importance of hypoxia and the HIF-1alpha pathways may therefore hold the key to prevention strategies, improved selection of patients for adjuvant therapy and new treatments for the disease.en
dc.language.isoenen
dc.subjectCancer Proteinsen
dc.subjectStomach Canceren
dc.subjectTumour Markersen
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidal-
dc.subject.meshAntigens, Neoplasm-
dc.subject.meshCarbonic Anhydrases-
dc.subject.meshCell Hypoxia-
dc.subject.meshCyclooxygenase 2-
dc.subject.meshDrug Resistance, Neoplasm-
dc.subject.meshForecasting-
dc.subject.meshGenes, Tumor Suppressor-
dc.subject.meshGlucose Transporter Type 1-
dc.subject.meshHelicobacter Infections-
dc.subject.meshHelicobacter pylori-
dc.subject.meshHumans-
dc.subject.meshHypoxia-Inducible Factor 1, alpha Subunit-
dc.subject.meshImmunohistochemistry-
dc.subject.meshMicrocirculation-
dc.subject.meshNeoplasm Proteins-
dc.subject.meshPrognosis-
dc.subject.meshStomach Neoplasms-
dc.subject.meshTumor Markers, Biological-
dc.subject.meshVascular Endothelial Growth Factor A-
dc.titleIs the hypoxia-inducible factor pathway important in gastric cancer?en
dc.typeArticleen
dc.contributor.departmentDepartment of Gastrointestinal Surgery, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, South Moor Road, Wythenshawe, M23 9LT, UK.en
dc.identifier.journalEuropean Journal of Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.